This is not a simple case of a business closing its doors
Lifestyle and Self-Care Strategies Lifestyle habits cannot replace treatment, but they make recovery stronger and more sustainable
The pain can last for years
Fernandez-Barrena: Nothing to Disclose, Laura Alvarez: Nothing to Disclose, Colm O'Rourke: Nothing to Disclose, Pui-Yuen Lee-Law: Nothing to Disclose, Kyle Davies: Nothing to Disclose, Andreea Gradinaru: Nothing to Disclose, Raul Jimenez-Aguero: Nothing to Disclose, Adelaida La Casta: Nothing to Disclose, Ioana Riao: Nothing to Disclose, Rocio Macias: Nothing to Disclose, Jose J G Marin: Nothing to Disclose, Maria L Martinez-Chantar: Nothing to Disclose, Matias A Avila: Nothing to Disclose, Patricia Aspichueta: Nothing to Disclose, Jesper B Andersen: Nothing to Disclose, Luke Boulter: Nothing to Disclose, Luis Bujanda: Nothing to Disclose, Pedro M Rodrigues: Nothing to Disclose, Maria J Perugorria: Nothing to Disclose, Jesus M Banales: Nothing to Disclose 1936 THE INVOLVEMENT OF MICRORNA-1297 IN LENVATINIB RESISTANCE IN HEPATOCELLULAR CARCINOMA CELLS Takayuki Kogure 1 Mari Satoh 1 Takehito Ito 1 Kennichi Satoh 1 , 1 Tohoku Medical and Pharmaceutical University Background: Lenvatinib for treating hepatocellular carcinoma (HCC) has a superior response rate, although its overall survival is non-inferior to sorafenib, suggesting tumor cells may acquire resistance during therapy
Accessed 2 Mar 2023 Schieffer E, Schieffer B (2022) The rationale for the treatment of long-Covid symptomsa cardiologists view
While we acknowledge the opportunities raised by several commenters to use additional data sources to identify patients with likely social risk, we believe that our proposal to use QMB status is evidence-based, operationally feasible, and sufficiently sensitive to capture at-risk beneficiaries that require additional resources
